Considering the possible heterogeneous expression of these markers in different tumor samples, to assess the consistency of our findings, we performed IHC staining of MCT4, GLS, ACC, FAS and CPT1A in 8 additional samples obtained by implantation of the same specimen (LT66, LT111, LT141, LT 220, LT255, LT267, LT278, LT458) in different mice. This evidence concerns the gene GLS and neoplasm.